New England-area deal-making news came back with a roar in the last week. We saw headlines of stock sales, myriad stages of venture funding, acquisitions, and a top venture capital firm’s moves to raise money for a new fund.
—Etouches, a Ridgefield, CT-based meeting planning company turned software-as-a-service business, said it raised $2.5 million in its first round of venture capital funding, led by Greycroft Partners. Cava Capital and Connecticut Innovations also participated in the financing for etouches, which makes software for managing events.
—Healthrageous, a maker of software designed to give personalized medical advice on issues like weight loss and diabetes, raised $6 million in Series A funding. North Bridge Venture Partners led the investment, and is also housing the startup in its Waltham, MA, offices until it finds Boston-area office space. Egan-Managed Capital and Long River Ventures also kicked in cash, which will go to hiring more engineers and other staff, and development of a platform for smartphones.
—New Haven, CT-based antibiotics developer Rib-X Pharmaceuticals pulled in $5.5 million of a round of debt and options that could reach $15 million, an SEC filing showed. The company took in a new CEO in March and has raised more than $158 million before the newest funding, since its founding in 2000.
—Exogenesis, a Billerica, MA-based developer of technology for improving implantable medical devices’ interaction with the body, raised $3.7 million of a planned $4.1 million round of equity funding. The company lists members of Inflection Point Ventures and Venture Capital Fund of New England as members of the board, according to a regulatory filing.
—Sonicbids, whose website enables bands to discover and book gigs, said it acquired San Francisco-based ArtistData. No financial terms were disclosed for the deal, but Boston-based Sonicbids says that ArtistData, which serves as a platform for publishing gig information, will be
